Accolade (ACCD) Misses Q4 EPS by 15c

Go back to Accolade (ACCD) Misses Q4 EPS by 15c

Morgan Stanley Downgrades Accolade Inc. (ACCD) to Equalweight

April 29, 2022 5:48 AM EDT

Morgan Stanley analyst Ricky Goldwasser downgraded Accolade Inc. (NASDAQ: ACCD) from Overweight to Equalweight with a price target of $9.00 (from $30.00).

The analyst comments "We continue to like the long-term growth opportunity for Accolade and recognize sentiment is already very depressed. However, the loss... More